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a b s t r a c t
The streptozotocin-induced diabetic rat model was used to investigate the relation between
the deranged gut motility and the segment-specific quantitative changes in the nitrergic
myenteric neurons. Additionally, we studied the effectiveness of early insulin replacement
to prevent the diabetes-induced changes.
Rats were divided into three groups: controls, diabetics and insulin-treated diabetics. Ten
weeks after the onset of diabetes, animals were chosen from each group for intestinal
transit measurements. The remainder were killed and gut segments were processed for
NADPH-diaphorase histochemistry and HuC/HuD immunohistochemistry.
The diabetic rats displayed faster transit than that for the controls. In the insulin-treated
group, the transit time was the same as that in the controls. In the duodenum of the diabetic
rats, the number of nitrergic neurons was decreased, while the total neuronal number was
not altered. In the jejunum, ileum and colon, both the total and the nitrergic neuronal cell
number decreased significantly. Insulin treatment did not prevent the nitrergic cell loss
significantly in the duodenum and jejunum, but it did prevent it significantly in the ileum
and colon.
These findings comprise the first evidence that the nitrergic neurons located in different
intestinal segments exhibit different susceptibilities to a diabetic state and to insulin
treatment.
# 2008 Elsevier Ireland Ltd. All rights reserved.
avai lab le at www.sc iencedi rec t .com
journal homepage: www.e lsev ier .com/ locate /d iabres1. Introduction
The alterations in gastrointestinal motility, including diar-
rhea, observed in diabetic patients pose a major clinical
problem [1,2], they appear to be multifactorial in origin. The
changes include the dysfunction of extrinsic and/or intrinsic
neurons in the enteric nervous system [3,4]. It has recently
been demonstrated that the nitrergic subpopulation of* Corresponding author. Tel.: +36 62 544123; fax: +36 62 544123.
E-mail address: bmarcsi@bio.u-szeged.hu (M. Bagya´nszki).
0168-8227/$ – see front matter # 2008 Elsevier Ireland Ltd. All rights
doi:10.1016/j.diabres.2007.12.013
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ment of neuropathy in diabetes [5–7]. Since nitric oxide (NO) is
considered to be an important inhibitory neurotransmitter in
the gut, impairment of the nitrergic innervation in animal
models of diabetes may lead to the observed motility disorders
[8,9]. Nitrergic neuropathy has been shown to take place in two
phases [10]. The first phase, with the loss of neuronal nitric
oxide synthase (nNOS) in the neurons and a nitrergicreserved.
treatment prevents gut motility alterations and loss of nitrergic
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phase is characterized by neuronal apoptosis and is irrever-
sible on insulin replacement. Additionally, the preventive
effect of insulin replacement on nitrergic neuron loss has been
shown to be organ-dependent: it restored the decreased NOS
expression in the central nervous system, but failed to do so in
the kidney [9]. The data on the alterations in the nitrergic
neurons in different species and in the different segments of
the gastrointestinal tract are controversial. A reduced expres-
sion of nNOS and/or an impairment of NO-dependent
relaxation have been reported in the myenteric plexus of
the stomach [8,10–12], the duodenum [12], the colon [13] and
the human jejunum [14], whereas an increased expression and
thickening of nNOS-containing nerve fibers with increases in
the nNOS activity and the number of nitrergic neurons have
been observed in the ileum [15,16] of streptozotocin (STZ)-
diabetic rats. The number of nNOS-immunoreactive myen-
teric neurons has been reported to be unaffected in the gastric
antrum and duodenum of diabetic rats [17] and in the ileum of
STZ-treated guinea pigs [18]. In consequence of these contra-
dictory data, the mechanism through which the nitrergic
myenteric neurons are involved in the diabetic complications
is at present unclear.
The primary aim of the present study, therefore, was to
investigate the associations between the diabetes-induced
motility disorders and the alterations in the nitrergic
myenteric neurons in the different segments of the small
intestine and colon of the STZ-induced diabetic rat model
[4,19]. A secondary aim was to study the preventive effect of
early insulin replacement on the nitrergic neurons in different
gut regions and the relationship with the altered gut motility.
To follow the quantitative changes in the myenteric
neurons, the Plexus Pattern Analysis software developed in
our laboratory [20] was applied. This has previously proved to
be a reliable tool for analysis of the quantitative changes in the
myenteric plexus under pathological conditions [21].
It is well established that within the enteric nervous system
(ENS) the nNOS corresponds to nicotinamide adenine dinu-
cleotide phosphate-diaphorase (NADPH-d) [22,23]. To identify
the nitrergic neurons in the present study, therefore, we used
NADPH-d histochemistry [24]. Additionally, to determine the
total number of myenteric neurons, anti-HuC/D was utilized
as a pan-neuronal marker [25].
2. Materials and methods
2.1. Experimental animals and induction of diabetes
All the experimental and animal care procedures had received
approval from the Local Ethics Committee for Animal
Research Studies at the University of Szeged. Adult male
Wistar rats weighing 350–400 g, kept on standard laboratory
chow (LATI, Hungary) and with free access to drinking water,
were used in the study. The rats were divided into three
groups: age-matched controls (n = 10), STZ-induced diabetics
(n = 12) and STZ-induced diabetics with insulin replacement
(n = 12). The controls were treated with vehicle, while diabetes
was induced by a single intraperitoneal injection of STZ
(Sigma, USA) at 60 mg/kg [19]. Forty-eight hours later, thePlease cite this article in press as: F. Izbe´ki et al., Immediate insulin
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blood obtained from the cut tip of the tail by the glucose
oxidase method, using a portable blood glucose monitoring
device (D-Cont Personal, 77 Elektronika Kft., Hungary). The
animals were considered diabetic if the nonfasting blood
glucose concentration was higher than 18 mM. From this time
on, one group of hyperglycemic rats received a subcutaneous
injection of 2 U of insulin (Humulin M3, Lilly, USA) each
morning. Equivalent volumes of saline were given subcuta-
neously to the rats in the other diabetic and the control groups.
Nonfasting blood glucose levels were determined, and the
animals were weighed weekly in each group.
Ten weeks after the onset of diabetes, eight animals were
randomly chosen from each group and prepared for intestinal
transit measurements, while all the remainder were killed by
cervical dislocation and gut segments were processed for
morphological studies.
2.1.1. Assessment of small and large bowel transit and
measurement of intestinal weights
First the colonic, and 2 days later the small bowel transit was
assessed. The animals were fasted for 12 h before the
measurements, though water was allowed ad libitum until
2 h before the beginning of the transit studies.
The colonic transit was measured according to the method
described by Million et al. [26]. Briefly, a single 5-mm colored
plastic bead was inserted into the distal colon (3 cm past the
anus) with a plastic rod while each rat was under brief
isoflurane anesthesia. After the bead insertion, the conscious
rats were placed into individual cages without water or food.
The time required for expulsion of the bead (in min) was
monitored over 4 h.
The small bowel transit was measured by means of a
phenol red content assay as described previously [27]. The
animals received 2 ml phenol red (0.75 mg/ml) via an
orogastric cannula. The phenol red solution was enriched
with 1.5% methylcellulose, resulting in a semi-liquid bolus.
Thirty minutes later, the rats were sacrificed by cervical
dislocation. The abdomen was opened via a midline incision
and clamps were placed at the cardia, the pylorus and the
small intestine at the cecum. The small bowel was removed
and laid flat, its length was measured, and it was then divided
into four equal segments. The distal 10-cm segment of the
ileum was cut, rinsed in water, dried on soft paper tissue and
weighed. The intestinal segments were placed into separate
tubes and the phenol red contents were determined spectro-
photometrically as described previously [27]. The colon was
also removed and laid flat, and the 10-cm segment proximal to
the cecum was cut, rinsed in water, dried on soft tissue paper
and weighed.
2.1.2. Histomorphological studies of the gut samples
For morphological examinations, small intestinal and colon
segments were dissected and rinsed in 0.05 M phosphate
buffer (PB), pH 7.4. Samples were taken from the duodenum
1 cm from the pylorus, from the jejunum 5 cm distal to the
ligament of Treitz, from the ileum 5 cm proximal to the ileo-
cecal junction, and from the middle part of the colon. Codes
were assigned to the samples for purposes of blinded
histological evaluation. The gut segments were cut alongtreatment prevents gut motility alterations and loss of nitrergic
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paraformaldehyde solution buffered with 0.1 M PB. The
samples were then washed, and whole-mount preparations
were made and processed for NADPH-d histochemistry, HuC/
HuD immunohistochemistry and double staining with the two
markers. In all cases, tissues from insulin-treated (n = 4) and
untreated diabetic (n = 4) rats were processed in parallel with
those from age-matched controls (n = 2).
2.2. NADPH-d histochemistry
Whole-mount preparations were processed for NADPH-d histo-
chemistry by following the modified protocol of Scherer-Singler
et al. [24]. The whole-mounts were incubated in a solution
containingnitrobluetetrazolium(0.25 mg/ml),NADPH(1 mg/ml;
Sigma, USA) and Triton X-100 (0.5%) in PB buffer (0.1 M, pH 7.6)
for 45 min at 37 8C. The whole-mounts were mounted on
gelatin-coated slides in glycerol-PB, observed and photo-
graphed with a Zeiss Axiovert 200 M light microscope
equipped with an Axiocam HRc camera. Twenty digital
photographs of identical magnification, size and resolution
were taken from each intestinal segment. Data from 20
measured areas per animal per intestinal segment were
included in the present study. Stained cells in each digital
photograph were counted through use of the Plexus Pattern
Analysis software [20].
2.3. HuC/HuD immunohistochemistry and double labeling
with NADPH-d–HuC/HuD
Whole-mount preparations were immunostained as
described earlier [21]. For double labeling, whole-mounts
stained previously for NADPH-d were further processed for
immunohistochemistry. All incubations were carried out at
room temperature. After blocking of the preparations in PB
containing 0.1% bovine serum albumin, 10% normal goat
serum and 0.5% Triton X-100, they were incubated overnight
with anti-human neuronal protein HuC/HuD developed in
mouse (Molecular Probes, Eugene, OR; final dilution 1:20). After
washing in PB, whole-mounts were incubated with biotiny-
lated anti-mouse IgG (Amersham, Buckinghamshire, UK; final
dilution 1:100) for 4 h, followed by overnight incubation in
streptavidin-biotinylated horseradish peroxidase (Amersham;
final dilution 1:100). Peroxidase activity was revealed by
means of diaminobenzidine. Negative controls were per-Table 1 – Changes in body weight, nonfasting blood glucose c
and colon in control, untreated diabetic and insulin-treated di
Control (n = 10) Diabe
Body weight (g)
Initial 370  27
Final 525  22*
Average blood glucose (mM/l) 5.3  0.8
Small bowel length (cm) 112  6.8
Ileum weight (mg/10 cm) 775  46
Colon weight (mg/10 cm) 857  71
* Statistical significance at a level of P < 0.05.
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eactivity was observed.
Whole-mounts were mounted on gelatin-coated slides in
glycerol-PB, observed and photographed as described above.
2.4. Statistical analysis
The small bowel transit was characterized by the extent of
phenol red recovery from the intestinal segments. The data
obtained from the age-matched controls were compared with
those from the untreated and the insulin-treated diabetics.
The results are expressed as means  S.E.M. and the statistical
significance of differences between groups was calculated by
ANOVA and Dunnett’s test.
The results of the immunohistochemical readings were
expressed as means  S.E.M. To evaluate the effects of STZ
treatment and insulin replacement on the number of nNOS-
stained and HuC/HuD-stained neurons, the statistical analysis
was performed by using one-way ANOVA and Newman–Keuls
test. All analyses were performed by using the SPSS 8.0
software package for Windows, and a probability P < 0.05 was
set as the level of significance.
3. Results
3.1. Immediate insulin treatment moderated the increase
in nonfasting blood glucose concentration and prevented the
body weight loss in STZ-induced diabetic rats
All of the diabetic rats used in this study displayed significantly
increased blood glucose levels. The nonfasting blood glucose
concentration in the untreated diabetic group was about four
times higher than that for the controls (Table 1). In the insulin-
treated group, the glucose levels on average remained below
10 mM, but this was still significantly higher than that for the
nondiabetic controls (Table 1). The untreated diabetic rats lost
weight significantly, whereas both the insulin-treated group
and the controls gainedweightduring thestudy period (Table 1).
Moreover, the weights of the corresponding segments of the
ileum and colon in both the insulin-treated and the untreated
diabetic rats were significantly greater than those in the control
rats (Table 1). Immediate insulin replacement, however,
significantly decreased the weights of the ileum and colon as
compared with the untreated diabetic values (Table 1).oncentration, length of small bowel and weights of ileum
abetic rats
tic untreated (n = 12) Diabetic insulin-treated (n = 12)
378  30 373  22
322  41* 508  40*
23.8  5.1* 8.6  1.9*
145  7.4* 119  7.7
1635  173 950  127*
1394  105* 1279  117*
treatment prevents gut motility alterations and loss of nitrergic
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the STZ-induced acceleration of the small intestinal and colonic
transit
The distal colonic transit, measured in terms of the bead
expulsion time, was significantly faster in the untreated
diabetic group than in the control group (79  39 min vs.
115  36 min; P < 0.05), while in the insulin-treated group the
colonic transit was not altered (Fig. 1A).
As compared with the control group, a significant shift to
the right was observed in the percentages of recovered phenol
red in the untreated diabetic rats, with a decrease in the first
(12.7  2.5% vs. 7.3  2%; P < 0.001) and an increase in the
fourth (6.2  2% vs. 25.5  10.9%; P < 0.001) segment (Fig. 1B).
This indicated an accelerated small intestinal transit in theFig. 1 – (A) Insulin replacement prevented the increase in
colonic transit in rats with STZ-induced diabetes. The
bead expulsion time was significantly shorter in the
untreated diabetic group (n = 8) than in the control group
(n = 8). In the insulin-treated group (n = 8), the colonic
transit did not differ from that in the controls. Data are
given as meansW S.E.M.; an asterisk indicates statistical
significance at a level of P < 0.05. (B) Insulin replacement
prevented the acceleration of small intestinal transit in
rats with STZ-induced diabetes. As compared with the
control values (n = 8), the percentage of recovered phenol
red in the untreated diabetic rats (n = 8) was significantly
decreased in the first and second intestinal segments,
whereas it was significantly increased in the third and
fourth intestinal segments, which indicates an accelerated
small intestinal transit. The distribution of the recovered
phenol red did not differ significantly between the controls
and the insulin-treated group (n = 8). Data are given as
meansW S.E.M.; an asterisk indicates statistical
significance at a level of P < 0.02.
Fig. 2 – Representative micrographs of anti-human HuC/
HuD-immunostained (A) whole-mount preparations of the
myenteric plexus of the duodenum from control rats, used
to count the total neurons, and NADPH-d-stained (B)
whole-mount preparations from the same intestinal
segment, used to count the nitrergic neurons. The
calibration bar denotes 50 mm in both micrographs.
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the recovered phenol red among the intestinal segments did
not differ significantly between the control and the insulin-
treated groups, as an indication of a preventive effect of
insulin treatment (Fig. 1B).
3.3. The influence of immediate insulin replacement on the
densities of the total and nitrergic myenteric neurons was
dependent on the intestinal segment under investigation
The densities of HuC/HuD-immunoreactive and NADPH-d-
stained myenteric neurons were evaluated in the duodenum,
jejunum, ileum and colon in each group of rats. HuC/HuD was
used as a pan-neuronal marker (Fig. 2A), while NADPH-d
histochemistry was applied to label nitrergic myenteric
neurons (Fig. 2B). The NADPH-d-stained cells were considered
to be nitrergic neurons when they were double-labeled with
HuC/HuD (Fig. 3). With the exception of the duodenum, the
density of the total myenteric neurons was decreased
significantly in all intestinal segment of the untreated diabetic
group of rats as compared with the vehicle-treated controltreatment prevents gut motility alterations and loss of nitrergic
uced diabetes, Diab. Res. Clin. Pract. (2008), doi:10.1016/
Fig. 3 – Representative micrographs of whole-mount
preparations of the myenteric plexus of the duodenum
from control rats double-labeled with HuC/HuD and
NADPH-d. All nitrergic neurons were double-labeled for
the two markers (inset). The calibration bar denotes 50 mm
in the whole picture and 30 mm in the inset.
Fig. 5 – Densities of NADPH-d-positive myenteric neurons
in the duodenum, jejunum, ileum and colon of control (C),
diabetic (D) and insulin-treated diabetic (ID) rats. Data are
expressed as meansW S.E.M. Significant differences
between the control and the treated groups are indicated
by asterisks. ***P < 0.001. Significant differences between
the insulin-treated and the untreated diabetic group are
indicated by circles. *P < 0.05, ***P < 0.001.
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density was most pronounced in the jejunum (50%;
P < 0.001). In contrast, the density of the total myenteric
neurons in the duodenum was practically the same in each
group of rats. The insulin replacement partially prevented the
decrease in total neuronal density in the jejunum and ileum,
while it completely prevented it in the colon (Fig. 4). The
density of nitrergic myenteric neurons was significantly lower
(35–45%) in all intestinal segments in the untreated diabetic
group of rats as compared with the vehicle-treated control
group (Fig. 5). The decrease in the nitrergic myenteric neuronal
density was not prevented significantly in the duodenum and
jejunum after insulin replacement, whereas in the ileum and
colon the prevention was significant in the insulin-treated
diabetics (Fig. 5).Fig. 4 – Densities of HuC/HuD-immunoreactive myenteric
neurons in the duodenum, jejunum, ileum and colon of
control (C), diabetic (D) and insulin-treated diabetic (ID)
rats. Data are expressed as meansW S.E.M. Significant
differences between the control and the treated groups are
indicated by asterisks. *P < 0.05, ***P < 0.001. Significant
differences between the insulin-treated and the untreated
diabetic group are indicated by circles. ***P < 0.001.
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The two major parameters characterizing the diabetes in the
STZ-induced diabetic rats were weight loss and hyperglyce-
mia. The insulin-treated diabetic rats exhibited an increase in
body weight during the study period which was similar to that
for the control animals, without any significant difference at
the end. Their blood glucose level was significantly lower than
that of the untreated diabetics, though all of the insulin-
treated diabetic rats were still hyperglycemic. Literature
findings [19,28] suggest that this hyperglycemia might be
responsible for the intestinal hyperplasia we observed despite
insulin replacement.
The STZ-induced diabetic rats displayed faster small
intestinal and colonic transit, as observed by others in
different rat models of diabetes [5,29,30]. We therefore infer
that our observations in this model with regard to the changes
in the total myenteric neurons and the nitrergic subpopulation
furnish data on the pathogenesis of diabetic diarrhea, which is
a serious complication of diabetes in approximately 10% of
diabetic patients [1,2].
In the gastrointestinal tract of STZ-induced diabetic rats,
nNOS-containing neurons appear to be vulnerable to the
effects of diabetes, but the available reports focusing only on
separate segments of the gastrointestinal tract are somewhat
contradictory. In rat models of diabetes, both increases
[15,16] and decreases [29,31] in NOS protein expression and/
or the impairment of NO-dependent relaxation have been
reported.
It is well established that NADPH-d is a reliable marker for
nNOS-containing neurons in the mammalian [22] and avian
[23,32] gut. In the present study, the NADPH-d-stained cells
were considered to be nitrergic neurons when they were
double-labeled with Huc/HuD used as a pan-neuronal marker
[25]. In our experiments, the diabetic rats demonstrated atreatment prevents gut motility alterations and loss of nitrergic
uced diabetes, Diab. Res. Clin. Pract. (2008), doi:10.1016/
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nitrergic neurons in the myenteric plexus; however, the
susceptibilities to the diabetic state and also to insulin
treatment of the nitrergic neurons in the different intestinal
regions varied distinctly. While the densities of both the total
and the nitrergic neurons decreased significantly in the
jejunum, the decrease in neuronal density in the duodenum
was restricted exclusively to the nitrergic neurons. Since the
total neuronal density indicated by Huc/HuD staining did not
change in the duodenum of the untreated diabetic rats as
compared with the control group, we concluded that the
myenteric neurons did not die in this particular gut segment.
Furthermore, it is well established that NADPH-d corresponds
completely to nNOS within the ENS [22], and NADPH-d activity
in the nitrergic neurons coincides with the nNOS activity [33].
Accordingly, we suggest that the decreased density of nitrergic
neurons in the duodenum of untreated diabetic rats reflects an
impairment of the nNOS pathways, rather than the necrotic or
apoptotic death of the nitrergic neurons. This suggestion is
consistent with our recent finding [21] of decreases in nNOS
activity and nNOS protein content behind the reduced number
of nitrergic myenteric neurons in an alcoholic rat model. Since
the decrease in nitrergic neuronal density was the same in the
duodenum of the untreated and the insulin-treated diabetic
rats, we presumed that the impairment of the NOS pathways
in the duodenum was independent of the insulin deficiency.
Otherwise, the enhancement of the preventive effect of early
insulin replacement on the decrease in density of both the
total and the nitrergic myenteric neurons was well pro-
nounced in the aboral direction. The neuronal density in the
jejunum after insulin replacement was still significantly lower
than that in the controls; the difference between the controls
and the insulin-treated diabetics was no longer significant in
the ileum; whereas the nitrergic neuronal density in the colon
was the same in the insulin-treated diabetics as that in the
control group. In conclusion, our present results correlate well
with previously reported data which proved that the gastro-
intestinal malfunction in diabetes includes changes in the
myenteric nitrergic neurons. However, the evidence published
here has revealed for the first time the different suscept-
ibilities of nitrergic neurons located in different intestinal
segments to diabetic damage, and also their different levels of
responsiveness to insulin treatment. The exact nature of these
differences warrants further investigations. However, these
findings imply that the development of the diabetic nitrergic
neuropathy is more complicated than suggested earlier [10]
and it differs from segment to segment along the gastro-
intestinal tract.
Conflicts of interest
The authors state that they have no conflict of interest.
Acknowledgements
The study was supported by the Hungarian National Grant
Agency, Grant#F46201 to MB, and by the National Office for
Research and Technology, RET-08/2004 to FI, TW and AR.Please cite this article in press as: F. Izbe´ki et al., Immediate insulin
neurons in the ileum and colon of rats with streptozotocin-ind
j.diabres.2007.12.013r e f e r e n c e s
[1] P. Bytzer, N.J. Talley, M. Leemon, L.J. Young, M.P. Jones, M.
Horowitz, Prevalence of gastrointestinal symptoms
associated with diabetes mellitus: a population-based
survey of 15,000 adults, Arch. Intern. Med. 161 (2001) 1989–
1996.
[2] J.A. Ricci, R. Siddique, W.F. Stewart, R.S. Sandler, S. Sloan,
C.E. Farup, Upper gastrointestinal symptoms in a U.S.
national sample of adults with diabetes, Scand. J.
Gastroenterol. 35 (2000) 152–159.
[3] A. Keshavarzian, F.L. Iber, Gastrointestinal involvement in
insulin-requiring diabetes mellitus, J. Clin. Gastroenterol. 9
(1987) 685–692.
[4] A. Roszto´czy, R. Ro´ka, T.T. Va´rkonyi, C. Lengyel, F. Izbe´ki, J.
Lonovics, et al., Regional differences in the manifestation of
gastrointestinal motor disorders in type 1 diabetic patients
with autonomic neuropathy, Z. Gastroenterol. 42 (2004)
1295–1300.
[5] K. Korenaga, M.A. Micci, G. Taglialatela, P.J. Pasricha,
Suppression of nNOS expression in rat enteric
neurones by the receptor for advanced glycation
end-products, Neurogastroenterol. Motil. 18 (2006)
392–400.
[6] M. Camilleri, J.R. Malagelada, Abnormal intestinal motility
in diabetics with the gastroparesis syndrome, Eur. J. Clin.
Invest. 14 (1984) 420–427.
[7] S. Cellek, W. Qu, A.M. Schmidt, S. Moncada, Synergistic
action of advanced glycation end products and endogenous
nitric oxide leads to neuronal apoptosis in vitro: a new
insight into selective nitrergic neuropathy in diabetes,
Diabetologia 47 (2004) 331–339.
[8] C.C. Watkins, A. Sawa, S. Jaffrey, S. Blackshaw, R.K. Barrow,
S.H. Snyder, Insulin restores neuronal nitric oxide synthase
expression and function that is lost in diabetic gastropathy,
J. Clin. Invest. 106 (2000) 373–384.
[9] W.J. Yu, S.W. Juang, W.T. Chin, T.C. Chi, C.J. Chang, J.T.
Cheng, Insulin restores neuronal nitric oxide synthase
expression in streptozotocin-induced diabetic rats, Life Sci.
68 (2000) 625–634.
[10] S. Cellek, N.A. Foxwell, S. Moncada, Two phases of nitrergic
neuropathy in streptozotocin-induced diabetic rats,
Diabetes 52 (2003) 2353–2362.
[11] M.A. Martinez-Cuesta, H. Massuda, B.J. Whittle, S.
Moncada, Impairment of nitrergic-mediated relaxation of
rat isolated duodenum by experimental diabetes, Br. J.
Pharmacol. 114 (1995) 919–924.
[12] A. Spangeus, O. Suhr, M. El-Salhy, Diabetic state
affects the innervation of gut in an animal model of
human type 1 diabetes, Histol. Histopathol. 15 (2000)
739–744.
[13] S. Yoneda, M. Kadowaki, H. Kuramoto, H. Fukui, M. Takaki,
Enhanced colonic peristalsis by impairment of nitrergic
enteric neurons in spontaneously diabetic rats, Auton.
Neurosci. 92 (2001) 65–71.
[14] C.L. He, E.E. Soffer, C.D. Ferris, R.M. Walsh, J.H.
Szurszewski, G. Farrugia, Loss of interstitial cells of Cajal
and inhibitory innervation in insulin-dependent diabetes,
Gastroenterology 121 (2001) 427–434.
[15] H.R. Shotton, S. Clarke, J. Lincoln, The effectiveness of
treatments of diabetic autonomic neuropathy is not the
same in autonomic nerves supplying different organs,
Diabetes 52 (2003) 157–164.
[16] J.N. Zanoni, N.C. Buttow, R.B. Bazotte, M.H. Miranda Neto,
Evaluation of the population of NADPH-diaphorase-stained
and myosin-V myenteric neurons in the ileum of
chronically streptozotocin-diabetic rats treated with
ascorbic acid, Auton. Neurosci. 104 (2003) 32–38.treatment prevents gut motility alterations and loss of nitrergic
uced diabetes, Diab. Res. Clin. Pract. (2008), doi:10.1016/
d i a b e t e s r e s e a r c h and c l i n i c a l p r a c t i c e x x x ( 2 0 0 8 ) x x x – x x x 7
DIAB-4088; No of Pages 7[17] E. Adeghate, B. al-Ramadi, A.M. Saleh, C. Vijayarasathy,
A.S. Ponery, K. Arafat, et al., Increase in neuronal nitric
oxide synthase content of the gastroduodenal tract of
diabetic rats, Cell. Mol. Life Sci. 60 (2003) 1172–1179.
[18] K.J. LePard, Choline acetyltransferase and inducible nitric
oxide synthase are increased in myenteric plexus of
diabetic guinea pig, Auton. Neurosci. 118 (2005) 12–24.
[19] H.P. Schedl, H.D. Wilson, Effect of diabetes on intestinal
growth and hexose transport in the rat, J. Physiol. 220 (1971)
1739–1745.
[20] V. Roman, M. Bagya´nszki, M. Krecsmarik, A. Horva´th, B.A.
Resch, E. Fekete, Spatial pattern analysis of nitrergic
neurons in the developing myenteric plexus of the human
fetal intestine, Cytometry 57A (2004) 108–112.
[21] M. Krecsmarik, F. Izbe´ki, M. Bagya´nszki, N. Linke, N. Bo´di, J.
Kaszaki, et al., Chronic ethanol exposure impairs neuronal
nitric oxide synthase in the rat intestine, Alcohol. Clin. Exp.
Res. 30 (2006) 967–973.
[22] J.P. Timmermans, M. Barbiers, D.W. Scheuerman, J.J.
Bogers, D. Adriaensen, E. Fekete, et al., Nitric oxide
synthase immunoreactivity in the enteric nervous system
of the developing human digestive tract, Cell Tissue Res.
275 (1994) 235–245.
[23] C. Balaskas, M.J. Saffrey, G. Burnstock, Distribution of
NADPH-diaphorase activity in the embryonic chicken gut,
Anat. Embryol. (Berl.) 192 (1995) 239–245.
[24] U. Scherer-Singler, S.R. Vincent, H. Kimura, E.G. McGeer,
Demonstration of a unique population of neurons with
NADPH-diaphorase histochemistry, J. Neurosci. Methods 9
(1983) 229–234.
[25] R.J. Phillips, S.L. Hargrave, B.S. Rhodes, D.A. Zopf, T.L.
Powley, Quantification of neurons in the myenteric plexus:
an evaluation of putative pan-neuronal markers, J.
Neurosci. Methods 133 (2004) 99–107.Please cite this article in press as: F. Izbe´ki et al., Immediate insulin
neurons in the ileum and colon of rats with streptozotocin-ind
j.diabres.2007.12.013[26] M. Million, C. Maillot, P. Saunders, J. Rivier, W. Vale, Y.
Tache´, Human urocortin II, a new CRF-related peptide,
displays selective CRF2-mediated action on gastric transit
in rats, Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002)
G34–G40.
[27] F. Izbe´ki, T. Wittmann, S. Csa´ti, E. Jeszenszky, J. Lonovics,
Opposite effects of acute and chronic administration of
alcohol on gastric emptying and small bowel transit in rat,
Alcohol Alcoholism 36 (2001) 304–308.
[28] R.N. Fedorak, E.B. Chang, M. Field, Intestinal adaptation to
diabetes. Altered Na-dependent nutrient absorption in
streptozotocin-treated chronically diabetic rats, J. Clin.
Invest. 79 (1987) 1571–1578.
[29] I. Kaputlu, S. Ozdem, G. Sadan, O. Gokalp, Effects of
diabetes on non-adrenergic, non-cholinergic relaxation
induced by GABA and electrical stimulation in the rat
isolated duodenum, Clin. Exp. Pharmacol. Physiol. 26 (1999)
724–728.
[30] K. Yamada, M. Hosokawa, S. Fujimoto, K. Nagashima, K.
Fukuda, H. Fujiwara, et al., The spontaneously diabetic
Torii rat with gastroenteropathy, Diabetes Res. Clin. Pract.
75 (2007) 127–134.
[31] N. Suthamnatpong, F. Hata, A. Kanada, T. Takeuchi, O.
Yagasaki, Mediators of nonadrenergic, noncholinergic
inhibition in the proximal, middle and distal regions of rat
colon, Br. J. Pharmacol. 108 (1993) 348–355.
[32] M. Bagya´nszki, V. Roma´n, E. Fekete, Quantitative
distribution of NADPH-diaphorase-positive myenteric
neurons in different segments of the developing chicken
small intestine and colon, Histochem. J. 32 (2000) 679–684.
[33] I. Soto, T. Lo´pez-Roca, J.M. Blagburn, R.E. Blanco, Changes
in nNOS and NADPH diaphorase in frog retina and tectum
after axotomy and FGF-2 application, Brain Res. 1103 (2006)
65–75.treatment prevents gut motility alterations and loss of nitrergic
uced diabetes, Diab. Res. Clin. Pract. (2008), doi:10.1016/
